Total Payments
$21,141
2024 Payments
$4,504
Companies
70
Transactions
656
Medicare Patients
3,643
Medicare Billing
$560,428
Payment Breakdown by Category
Food & Beverage$16,056 (75.9%)
Travel$2,714 (12.8%)
Other$2,250 (10.6%)
Education$120.88 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,056 | 644 | 75.9% |
| Travel and Lodging | $2,714 | 9 | 12.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,250 | 1 | 10.6% |
| Education | $120.88 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,706 | 79 | $0 (2024) |
| UCB, Inc. | $2,203 | 48 | $0 (2024) |
| Medtronic Vascular, Inc. | $1,457 | 7 | $0 (2017) |
| Ipsen Innovation | $1,042 | 4 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $864.76 | 24 | $0 (2024) |
| EMD Serono, Inc. | $816.60 | 21 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $732.68 | 24 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $638.95 | 42 | $0 (2024) |
| PFIZER INC. | $616.76 | 34 | $0 (2024) |
| MDD US Operations, LLC | $566.38 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,504 | 203 | ABBVIE INC. ($574.90) |
| 2023 | $6,947 | 204 | UCB, Inc. ($1,464) |
| 2022 | $4,340 | 87 | ABBVIE INC. ($2,461) |
| 2021 | $351.61 | 5 | Teva Pharmaceuticals USA, Inc. ($237.05) |
| 2020 | $207.71 | 19 | Allergan, Inc. ($118.17) |
| 2019 | $314.71 | 6 | Alexion Pharmaceuticals, Inc. ($139.11) |
| 2018 | $138.25 | 2 | Medtronic USA, Inc. ($123.88) |
| 2017 | $4,338 | 130 | Medtronic Vascular, Inc. ($1,457) |
All Payment Transactions
656 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: Neurology | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.28 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $1.51 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $1.06 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.82 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: PAIN | ||||||
| 12/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 12/03/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 12/02/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Rare Disease | ||||||
| 11/26/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $6.02 | General |
| Category: NEUROLOGY | ||||||
| 11/22/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Neuropsychiatry | ||||||
| 11/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.23 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Neuroscience | ||||||
| 11/12/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: PAIN | ||||||
| 11/07/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $29.27 | General |
| 11/05/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Musculoskeletal | ||||||
| 10/31/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $33.96 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,282 | 11,879 | $1.1M | $211,541 |
| 2022 | 15 | 955 | 10,398 | $641,140 | $150,535 |
| 2021 | 11 | 703 | 6,296 | $400,836 | $115,706 |
| 2020 | 11 | 703 | 942 | $319,127 | $82,645 |
Total Patients
3,643
Total Services
29,515
Medicare Billing
$560,428
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 321 | 510 | $286,620 | $53,671 | 18.7% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 16 | 10,200 | $244,800 | $50,385 | 20.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 243 | 320 | $127,040 | $22,980 | 18.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 132 | 219 | $95,175 | $17,485 | 18.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 118 | 118 | $86,140 | $15,830 | 18.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 105 | 108 | $86,702 | $15,117 | 17.4% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 57 | 59 | $56,640 | $9,820 | 17.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 16 | 54 | $41,688 | $8,089 | 19.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 62 | 62 | $30,607 | $5,859 | 19.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 15 | 15 | $28,710 | $5,281 | 18.4% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 32 | 48 | $13,440 | $2,426 | 18.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 119 | 119 | $9,163 | $2,271 | 24.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 26 | 27 | $6,534 | $1,224 | 18.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 20 | 20 | $6,400 | $1,102 | 17.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 21 | 9,255 | $184,590 | $45,377 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 193 | 239 | $109,898 | $24,441 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 249 | 350 | $95,530 | $23,676 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 86 | 86 | $59,855 | $12,136 | 20.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 34 | 34 | $32,674 | $10,025 | 30.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 106 | 106 | $42,515 | $9,056 | 21.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 21 | 56 | $33,832 | $8,259 | 24.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 38 | 52 | $21,468 | $4,372 | 20.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 30 | 30 | $22,938 | $4,366 | 19.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $10,432 | $2,292 | 22.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 110 | 110 | $8,470 | $2,086 | 24.6% |
About Dr. Jonathan Cross, MD
Dr. Jonathan Cross, MD is a Neurology healthcare provider based in Aventura, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1336146927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Cross, MD has received a total of $21,141 in payments from pharmaceutical and medical device companies, with $4,504 received in 2024. These payments were reported across 656 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($16,056).
As a Medicare-enrolled provider, Cross has provided services to 3,643 Medicare beneficiaries, totaling 29,515 services with total Medicare billing of $560,428. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Aventura, FL
- Active Since 06/28/2005
- Last Updated 09/30/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1336146927
Products in Payments
- UBRELVY (Drug) $2,796
- Dysport (Drug) $1,042
- Briviact (Drug) $880.41
- APTIOM (Drug) $709.49
- NURTEC ODT (Drug) $501.91
- Apokyn (Drug) $495.99
- QULIPTA (Drug) $419.14
- INGREZZA (Drug) $397.43
- BOTOX (Biological) $362.61
- AJOVY (Biological) $346.90
- VYEPTI (Biological) $344.52
- ULTOMIRIS (Biological) $341.62
- REXULTI (Drug) $329.42
- MAVENCLAD (Drug) $283.81
- VNS Therapy (Device) $281.69
- VYVGART HYTRULO (Drug) $261.49
- INFINITY (Device) $253.75
- Ongentys (Drug) $241.52
- NUPLAZID (Drug) $239.97
- Nourianz (Drug) $215.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Aventura
Dr. Jeffrey Gelblum, Md, MD
Neurology — Payments: $293,446
Neurology $293,446
Dr. Luis Becerra-Cabal, M.d, M.D
Neurology — Payments: $19,395
Neurology $19,395
Dr. Raul Grosz, Md, MD
Neurology — Payments: $9,540
Neurology $9,540
Dr. Michael Crimmins, Md, MD
Neurology — Payments: $3,424
Neurology $3,424
Theodore Wein, Md, MD
Neurology — Payments: $549.40
Neurology $549.40
Dr. Sheryl Strasser, Md, MD
Neurology — Payments: $288.74
Neurology $288.74